Imaging the penumbra in acute stroke

Current Atherosclerosis Reports

Volumn 8, Issue 4, 2006, Pages 281-289

  Moustafa, Ramez R ^b   Baron, Jean Claude ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; ALTEPLASE; DESMOTEPLASE; FIBRINOLYTIC AGENT; GADOLINIUM; INSULIN; IODINATED CONTRAST MEDIUM; OXYGEN;

AGE; BRAIN CIRCULATION; BRAIN OXYGEN TENSION; BRAIN RADIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEASIBILITY STUDY; GRAY MATTER; HEMATOCRIT; HUMAN; HYPERGLYCEMIA; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONCENTRATION; OXYGEN THERAPY; PATIENT SAFETY; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUANTITATIVE DIAGNOSIS; RECANALIZATION; REPERFUSION; REVIEW; SENSITIVITY AND SPECIFICITY; WHITE MATTER;

ACUTE DISEASE; BRAIN; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; STROKE;

EID: 33745900216     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-006-0005-0     Document Type: Review

References (74)

1. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981, 12:723-725.
2. Baron JC: Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001, 11(Suppl 1):2-8.
3. Dewar D, Yam P, McCulloch J: Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol 1999, 375:41-50.
4. Falcao AL, Reutens DC, Markus R, et al.: The resistance to ischemia of white and gray matter after stroke. Ann Neurol 2004, 56:695-701.
5. Koga M, Reutens DC, Wright P, et al.: The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke. Stroke 2005, 36:2132-2137.
6. Simon JE, Bristow MS, Lu H, et al.: A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. J Cereb Blood Flow Metab 2005, 25:1236-1243.
7. Bristow MS, Simon JE, Brown RA, et al.: MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 2005, 25:1280-1287.
8. Ostrem JL, Saver JL, Alger JR, et al.: Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004, 35:e30-34.
9. Montavont A, Nighoghossian N, Derex L, et al.: Intravenous r-TPA in vertebrobasilar acute infarcts. Neurology 2004, 62:1854-1856.
10. Pialat JB, Wiart M, Nighoghossian N, et al.: Evolution of lesion volume in acute stroke treated by intravenous t-PA. J Magn Reson Imaging 2005, 22:23-28.
11. Weimar C, Konig IR, Kraywinkel K, et al.: Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004, 35:158-162.
12. Bruno A, Biller J, Adams HP Jr. et al.: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52:280-284.
13. Gagnon DR, Zhang TJ, Brand FN, Kannel WB: Hematocrit and the risk of cardiovascular disease - the Framingham study: a 34-year follow-up. Am Heart J 1994, 127:674-682.
14. Parsons MW, Barber PA, Desmond PM, et al.: Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002, 52:20-28.
15. Baird TA, Parsons MW, Phanh T, et al.: Persistent post-stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34:2208-2214.
16. Garg R, Chaudhuri A, Munschauer F, Dandona P: Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006, 37:267-273.
17. Ay H, Koroshetz WJ, Vangel M, et al.: Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005, 36:2632-2636.
18. Allport LE, Parsons MW, Butcher KS, et al.: Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 2005, 65:1382-1387.
19. Singhal AB, Benner T, Roccatagliata L, et al.: A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005, 36:797-802.
20. Nakajima S, Meyer JS, Amano T, et al.: Cerebral vasomotor responsiveness during 100% oxygen inhalation in cerebral ischemia. Arch Neurol 1983, 40:271-276.
21. Rusyniak DE, Kirk MA, May JD, et al.: Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke 2003, 34:571-574.
22. Fiehler J, Remmele C, Kucinski T, et al.: Reperfusion after severe local perfusion deficit precedes hemorrhagic transformation: art MRI study in acute stroke patients. Cerebrovasc Dis 2005, 19:117-124.
23. Selim M, Fink JN, Kumar S, et al.: Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002, 33:2047-2052.
24. Alsop DC, Makovetskaya E, Kumar S, et al.: Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke. Stroke 2005, 36:746-750.
25. Latour LL, Kang DW, Ezzeddine MA, et al.: Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004, 56:468-477.
26. Warach S, Latour LL: Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004, 35:2659-2661.
27. Hjort N, Christensen S, Solling C, et al.: Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann Neurol 2005, 58:462-465.
28. Lin W, Lee JM, Lee YZ, et al.: Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003, 34:64-70.
29. Hamon M, Marie RM, Clochon P, et al.: Quantitative relationships between ADC and perfusion changes in acute ischemic stroke using combined diffusion-weighted imaging and perfusion MR (DWI/PMR). J Neuroradiol 2005, 32:118-124.
30. Nicoli F, Lefur Y, Denis B, et al.: Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study. Stroke 2003, 34:e82-87.
31. Guadagno JV, Warburton EA, Jones PS, et al.: The diffusion-weighted lesion in acute stroke: heterogeneous patterns of flow/metabolism uncoupling as assessed by quantitative positron emission tomography. Cerebrovasc Dis 2005, 19:239-246.
32. Guadagno JV, Warburton EA, Aigbirhio FI, et al.: Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study. J Cereb Blood Flow Metab 2004, 24:1249-1254.
33. Loh PS, Butcher KS, Parsons MW, et al.: Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke 2005, 36:2626-2631.
34. Kidwell CS, Saver JL, Mattiello J, et al.: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462-469.
35. Fiehler J, Knudsen K, Kucinski T, et al.: Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004, 35:514-519.
36. Suzuki S, Kidwell CS, Starkman S, et al.: Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. Stroke 2005, 36:e77-79.
37. Chalela JA, Kang DW, Luby M, et al.: Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era Ann Neurol 2004, 55:105-112.
38. Rivers CS, Wardlaw JM: What has diffusion imaging in animals told us about diffusion imaging in patients with ischaemic stroke? Cerebrovasc Dis 2005, 19:328-336.
39. Kidwell CS, Saver JL, Starkman S, et al.: Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol 2002, 52:698-703.
40. Thijs VN, Somford DM, Hammer R, et al.: Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging. Stroke 2004, 35:94-98.
41. Rose SE, Janke AL, Griffin M, et al.: Improved prediction of final infarct volume using bolus delay-corrected perfusion-weighted MRI: implications for the ischemic penumbra. Stroke 2004, 35:2466-2471.
42. Wu O, Ostergaard L, Koroshetz WJ, et al.: Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003, 50:856-864.
43. Sobesky J, Zaro Weber O, Lehnhardt FG, et al.: Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004, 35:2843-2847.
44. Grandin CB, Duprez TP, Smith AM, et al.: Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002, 223:361-370.
45. Butcher KS, Parsons M, MacGregor L, et al.: Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005, 36:1153-1159.
46. Schellinger PD, Latour LL, Wu CS, et al.: The association between neurological deficit in acute ischemic stroke and mean transit time Comparison of four different perfusion MRI algorithms. Neuroradiology 2005, 47:1-9.
47. Lee DH, Kang DW, Ahn JS, et al.: Imaging of the ischemic penumbra in acute stroke. Korean J Radiol 2005, 6:64-74.
48. Perkio J, Soinne L, Ostergaard L, et al.: Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 2005, 36:44-49.
49. Sobesky J, Zaro Weber O, Lehnhardt FG, et al.: Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005, 36:980-985.
50. Heiss WD, Sobesky J, Hesselmann V: Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004, 35:2671-2674.
51. Kang DW, Chalela JA, Dunn W, Warach S: MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 2005, 36:1939-1943.
52. Schellinger PD, Jansen O, Fiebach JB, et al.: Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. Am J Neuroradiol 2000, 21:1184-1189.
53. U-King-Im JM, Trivedi RA, Graves MJ, et al.: Utility of an ultrafast magnetic resonance imaging protocol in recent and semi-recent strokes. J Neurol Neurosurg Psychiatry 2005, 76:1002-1005.
54. Kidwell CS, Chalela JA, Saver JL, et al.: Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004, 292:1823-1830.
55. Hjort N, Butcher K, Davis SM, et al.: Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005, 36:388-397.
56. Hacke W, Albers G, Al-Rawi Y, et al.: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66-73.
57. Ribo M, Molina CA, Rovira A, et al.: Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005, 36:602-606.
58. Singer OC, Du Mesnil De Rochemont R, et al.: Early functional recovery and the fate of the diffusion/perfusion mismatch in patients with proximal middle cerebral artery occlusion. Cerebrovasc Dis 2004, 17:13-20.
59. Wintermark M, Sesay M, Barbier E, et al.: Comparative overview of brain perfusion imaging techniques. Stroke 2005, 36:e83-99.
60. Mayer TE, Hamann GF, Baranczyk J, et al.: Dynamic CT perfusion imaging of acute stroke. Am J Neuroradiol 2000, 21:1441-1449.
61. Schramm P, Schellinger PD, Klotz E, et al.: Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. Stroke 2004, 35:1652-1658.
62. Wintermark M, Fischbein NJ, Smith WS, et al.: Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke. Am J Neuroradiol 2005, 26:104-112.
63. Muir KW, Halbert HM, Baird TA, et al.: Visual evaluation of perfusion CT imaging in acute stroke accurately estimates infarct volume and tissue viability. J Neurol Neurosurg Psychiatry 2006, 77:334-339.
64. Fiorella D, Heiserman J, Prenger E, Partovi S: Assessment of the reproducibility of postprocessing dynamic CT perfusion data. Am J Neuroradiol 2004, 25:97-107.
65. Wintermark M, Reichhart M, Thiran JP, et al.: Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002, 51:417-432.
66. Wintermark M, Reichhart M, Cuisenaire O, et al.: Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002, 33:2025-2031.
67. Hellier KD, Hampton JL, Guadagno TV, et al.: Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 2006, In press.
68. Davalos A, Blanco M, Pedraza S, et al.: The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004, 62:2187-2192.
69. Prosser J, Butcher K, Allport L, et al.: Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005, 36:1700-1704.
70. Kent DM, Hill MD, Ruthazer R, et al.: "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke 2005, 36:1695-1699.
71. Butcher K, Lee SB, Parsons M, et al.: Increased blood volume maintains viability in tissue with isolated focal swelling on CT in acute stroke. Stroke 2005, 36:418.
72. Markus R, Reutens DC, Kazui S, et al.: Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 2004, 127:1427-1436.
73. Lee JM, Vo KD, An H, et al.: Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003, 53:227-232.
74. Walker PM, Ben Salem D, Lalande A, et al.: Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci 2004, 220:23-28.